Concepedia

Publication | Closed Access

Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal Adenocarcinoma

12

Citations

35

References

2015

Year

Abstract

AUY922 exhibits antitumor efficacy in vitro and in vivo for EAC, suggesting the need for human clinical trials.

References

YearCitations

Page 1